Panagora Asset Management’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.1M Sell
118,603
-88,251
-43% -$2.24M 0.01% 534
2026
Q1
$5.18M Buy
206,854
+128,518
+164% +$3.04M 0.02% 407
2025
Q4
$2.06M Sell
78,336
-27,736
-26% -$605K 0.01% 562
2025
Q3
$1.81M Buy
106,072
+72,513
+216% +$1.04M 0.01% 543
2025
Q2
$421K Buy
+33,559
New +$400K ﹤0.01% 843
2025
Q1
– Sell
-214,338
Closed -$3.14M – 1218
2024
Q4
$3.14M Buy
214,338
+113,472
+112% +$1.59M 0.01% 430
2024
Q3
$1.27M Buy
+100,866
New +$1.1M 0.01% 655

Other funds holding ZYME

Panagora Asset Management's ZYME Position: Q2 2026 in Review

Panagora Asset Management reduced its Zymeworks (ZYME) stake by 43% in Q2 2026, selling an estimated $2.24M and leaving 118,603 shares worth $3.1M. The position accounts for 0.01% of the portfolio, ranked #534.

Panagora Asset Management first reported a position in ZYME in Q3 2024 and has held it in 7 quarters since. The position peaked at $5.18M in Q1 2026. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Panagora Asset Management held 118,603 shares of Zymeworks worth $3.1M as of Q2 2026.
  • Panagora Asset Management sold 88,251 Zymeworks shares in Q2 2026, an estimated $2.24M.
  • Zymeworks made up 0.01% of Panagora Asset Management's portfolio in Q2 2026, its #534 holding.
  • Panagora Asset Management first reported a position in Zymeworks in Q3 2024 and has held it in 7 quarters since.
  • Panagora Asset Management's Zymeworks position peaked at $5.18M in Q1 2026.
  • 202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.